🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A total of 116 patients who meet the inclusion criteria and are chemotherap...
Status
Recruiting
Location
Imam khomeini hospital complex
Start Date
2025-01-20
Trial ID
NCT06555003
Treatments Being Tested
The purpose of this research study is to compare the effectiveness and safe...
Status
Terminated
Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Start Date
2023-09-27
Trial ID
NCT05537402
This is a prospective, single-arm, phase II clinical study designed to eval...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-01
Trial ID
NCT07543510
Treatments Being Tested
Study Objectives： Atezolizumab (anti-programmed death-ligand 1; anti-PD-L1)...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-15
Trial ID
NCT07168668
Treatments Being Tested
The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Status
Unknown
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2022-01-20
Trial ID
NCT05717738
There is an unmet need for patients with intermediate stage hepatocellular ...
Status
Terminated
Location
Yale New Haven Hospital
Start Date
2023-06-07
Trial ID
NCT05776875
Treatments Being Tested
This is a multicentre, open labeled, controlled phase study designed to ass...
Status
Completed
Location
Clearview Cancer Center
Start Date
2009-06
Trial ID
NCT00932438
Treatments Being Tested
The purpose of this study is to discuss the prognostic value of CEPH among ...
Status
Unknown
Location
Gao-Jun Teng
Start Date
2023-05-04
Trial ID
NCT05703750
Treatments Being Tested
This is a retrospective, multicenter, real-world cohort study designed to e...
Status
Active Not Recruiting
Location
Zhongda Hospital, Southeast University
Start Date
2020-10-28
Trial ID
NCT07204327
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Start Date
2026-05-13
Trial ID
NCT07645209
Treatments Being Tested